$3.41
-0.02 (-0.58%)
Open$3.43
Previous Close$3.43
Day High$3.46
Day Low$3.38
52W High$9.33
52W Low$4.29
Volume—
Avg Volume414.6K
Market Cap266.53M
P/E Ratio—
EPS$-1.58
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+493.0% upside
Current
$3.41
$3.41
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 472.69M | 408.37M | 70.84M |
| Net Income | 3.12M | 2.43M | 13.06M |
| Profit Margin | 0.7% | 0.6% | 18.4% |
| EBITDA | 20.17M | 16.55M | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +15.8% | +15.8% | +2.1% |
| Debt/Equity | 0.18 | 0.18 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |